Log in to save to my catalogue

A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants

A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7060076

A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants

About this item

Full title

A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants

Publisher

United States: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2020-01, Vol.382 (3), p.233-243

Language

English

Formats

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

In this multicenter, randomized trial involving extremely preterm infants, high-dose erythropoietin administered from 24 hours after birth through 32 weeks of postmenstrual age did not result in a lower risk of severe neurodevelopmental impairment or death at 2 years of age.

Alternative Titles

Full title

A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7060076

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7060076

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa1907423

How to access this item